, Rajthanee- Rojana Hospital’ s operation has improved substantially from the previous year. Going forward, business outlook is promising with the capacity expansion plan and significant growth of registered
electricity. Q1 2019 EBITDA rose considerably versus Q1 2018 an increase of 11% and while we face competition on volumes which may lead to revenue erosion the expectation is that the efforts on cost reduction
MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2018 While core EBITDA rose considerably versus 1Q 2017 an increase of 64% there were two considerable impacts on the overall EBITDA number. First
savings in logistics cost and electricity in the coming few months once the new operating procedures stabilize. EBITDA rose considerably versus Q2 2017 an increase of 35% as again the positive contribution
resulted in with further plans to increase these savings in 2019. Q3 2018 EBITDA rose considerably versus Q3 2017 an increase of 60% as again the positive contribution from higher volumes shows its effect
a decrease of 44.1 MB or 3.6% due to being in the effect of COVID-19. However, it considerably decreased compared to Q2–2020, representing a decrease of 542.0 MB or 31.3%. This is because in Q2–2020
loss of THB 629mn, mainly from a lower loss on impairment of assets of THB 355mn (THB 781mn in the previous year) Total assets as of 31 December 2018 stood at THB 53,964mn, growing considerably by 34.7
and cash equivalents was THB 1,240.09 million, increased by THB 503.83 million from 2017. Liquidity Ratio In 2018, the liquidity of the Company and its subsidiaries was considerably appropriate for its
. Liquidity Ratio In 2019, the liquidity of the Company and its subsidiaries was considerably appropriate for its operations and had strong financial position. As at December 31, 2019, the consolidated current
of drought in 2020. On the demand side, natural fatty alcohols in 2Q2020 has considerably slowed down from the same period of prior year, primarily due to the impact from COVID-19. To prevent the